PharmaCielo Ltd (PCLO.V)
0.195
+0.03
(+18.18%)
CAD |
TSXV |
Sep 27, 16:00
PharmaCielo Enterprise Value: 53.20M for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
September 27, 2024 | 53.20M |
September 26, 2024 | 48.11M |
September 25, 2024 | 49.81M |
September 24, 2024 | 42.17M |
September 23, 2024 | 40.47M |
September 20, 2024 | 39.62M |
September 19, 2024 | 39.62M |
September 18, 2024 | 39.62M |
September 17, 2024 | 39.62M |
September 16, 2024 | 39.62M |
September 13, 2024 | 38.78M |
September 12, 2024 | 35.38M |
September 11, 2024 | 36.23M |
September 10, 2024 | 36.23M |
September 09, 2024 | 37.08M |
September 06, 2024 | 38.78M |
September 05, 2024 | 37.93M |
September 04, 2024 | 38.78M |
September 03, 2024 | 37.08M |
August 30, 2024 | 38.78M |
August 29, 2024 | 38.78M |
August 28, 2024 | 42.17M |
August 27, 2024 | 42.17M |
August 26, 2024 | 43.87M |
August 23, 2024 | 43.02M |
Date | Value |
---|---|
August 22, 2024 | 39.62M |
August 21, 2024 | 38.78M |
August 20, 2024 | 40.47M |
August 19, 2024 | 43.02M |
August 16, 2024 | 43.87M |
August 15, 2024 | 41.32M |
August 14, 2024 | 40.47M |
August 13, 2024 | 41.32M |
August 12, 2024 | 37.08M |
August 09, 2024 | 37.93M |
August 08, 2024 | 40.47M |
August 07, 2024 | 40.47M |
August 06, 2024 | 43.02M |
August 02, 2024 | 40.47M |
August 01, 2024 | 43.02M |
July 31, 2024 | 43.87M |
July 30, 2024 | 43.02M |
July 29, 2024 | 42.17M |
July 26, 2024 | 43.02M |
July 25, 2024 | 43.02M |
July 24, 2024 | 42.17M |
July 23, 2024 | 44.72M |
July 22, 2024 | 45.56M |
July 19, 2024 | 46.41M |
July 18, 2024 | 46.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
33.06M
Minimum
Aug 18 2023
479.45M
Maximum
Sep 30 2019
117.12M
Average
71.86M
Median
Aug 29 2022
Enterprise Value Benchmarks
Biocure Technology Inc | 0.9566M |
Core One Labs Inc | 6.924M |
Nova Mentis Life Science Corp | 0.7895M |
Nanosphere Health Sciences Inc | 0.4221M |
Lobe Sciences Ltd | 4.758M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.575M |
Revenue (Quarterly) | 0.7837M |
Total Expenses (Quarterly) | 2.465M |
EPS Diluted (Quarterly) | -0.02 |
Gross Profit Margin (Quarterly) | 35.06% |
Profit Margin (Quarterly) | -328.6% |
Earnings Yield | -46.15% |
Normalized Earnings Yield | -34.67 |